R
R. Pozzan
Publications - 12
Citations - 86
R. Pozzan is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 5, co-authored 12 publications receiving 86 citations.
Papers
More filters
Journal ArticleDOI
Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS
Francesco Salton,Paola Confalonieri,Giuseppina Campisciano,Rossella Cifaldi,Clara Rizzardi,Daniele Generali,R. Pozzan,S. Tavano,C. Bozzi,Giulia Lapadula,Gianfranco Umberto Meduri,Marco Confalonieri,Manola Comar,Selene Lerda,Barbara Ruaro +14 more
TL;DR: Patients in the IMV group had higher inflammation levels at intubation than the NIV group, which may indicate a higher resistance to glucocorticoids, which could indicate a better control of inflammation and a better outcome.
Journal ArticleDOI
Chronic Thromboembolic Pulmonary Hypertension: An Update
Barbara Ruaro,Elisa Baratella,G. Caforio,Paola Confalonieri,Barbara Wade,Cristina Marrocchio,Pietro Geri,R. Pozzan,Alessia Giovanna Andrisano,Maria Assunta Cova,Maurizio Cortale,Marco Confalonieri,Francesco Salton +12 more
TL;DR: Pulmonary endarterectomy (PEA) reduces pulmonary vascular resistance, making it the treatment of choice and should be offered to operable CTEPH patients, as significant symptomatic and prognostic improvement has been observed.
Journal ArticleDOI
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat?
Barbara Ruaro,R. Pozzan,Paola Confalonieri,S. Tavano,Michael V. Hughes,Marco Matucci Cerinic,Elisa Baratella,Elisabetta Zanatta,Selene Lerda,Pietro Geri,Marco Confalonieri,Francesco Salton +11 more
TL;DR: A review investigating the correlation between GERD and IPF has confirmed the hypothesized association, but further large prospective studies are needed to corroborate and elucidate these findings with a focus on preventative and treatment strategies.
Journal ArticleDOI
An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients
Barbara Ruaro,Francesco Salton,Elisa Baratella,Paola Confalonieri,Pietro Geri,R. Pozzan,Chiara Torregiani,Roberta Bulla,Marco Confalonieri,Marco Matucci-Cerinic,Michael Hughes +10 more
TL;DR: The main tool to screen PAH is transthoracic echocardiography (TTE), which has a sensitivity of 90%, even if definitive diagnosis should be confirmed by right heart catheterization (RHC).
Journal ArticleDOI
Severe COVID-19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail?
Barbara Ruaro,Paola Confalonieri,R. Pozzan,S. Tavano,L. Mondini,Elisa Baratella,Alessandra Pagnin,Selene Lerda,Pietro Geri,Marco Biolo,Marco Confalonieri,Francesco Salton +11 more
TL;DR: Combining the administration of diluted, exogenous pulmonary surfactant via bronchoalveolar lavage along with the standard therapy for SARS-CoV-2-induced ARDS may be a promising way of improving the management of ARDS.